01
After years of preparation, over the past five years we have provided services to hundreds of organizations.
Cell Bank Characterization Services
Hundreds of projects have successfully passed NMPA and FDA review
Industry Recognition
Nearly 1,000 projects approved by CDE, FDA, EMA, and other regulatory agencies on the first submission
Product Coverage
Biological Products, CGT Products, Animal-derived Materials, Class II/III Medical Devices, Plasma-derived Products, etc.
Serving over 300 companies worldwide
Viral Clearance Validation Services (since 2012) and Cell Bank Characterization Services (since 2019)
Focus on biotechnology services
Attracting top talent and advanced equipment
Innovative Viral Inactivation Technologies and Products
(Liangchen Engineering Technology (Suzhou) Co., Ltd.)
Liangchen, as a pioneer in viral biosafety, has continuously pursued innovation in recent years, developing a series of novel viral inactivation devices and methods for biological products. Our expert R&D team focuses on viral clearance and biotechnological platform optimization.
